Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-145064
Filing Date
2023-05-15
Accepted
2023-05-15 16:24:24
Documents
68
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d502945d10q.htm   iXBRL 10-Q 773104
2 EX-31.1 d502945dex311.htm EX-31.1 10315
3 EX-31.2 d502945dex312.htm EX-31.2 10326
4 EX-32.1 d502945dex321.htm EX-32.1 4086
5 EX-32.2 d502945dex322.htm EX-32.2 4100
11 GRAPHIC g502945g31i84.jpg GRAPHIC 29670
  Complete submission text file 0001193125-23-145064.txt   5172583

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA txmd-20230331.xsd EX-101.SCH 51713
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE txmd-20230331_cal.xml EX-101.CAL 57062
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE txmd-20230331_def.xml EX-101.DEF 220305
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20230331_lab.xml EX-101.LAB 398800
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20230331_pre.xml EX-101.PRE 336957
62 EXTRACTED XBRL INSTANCE DOCUMENT d502945d10q_htm.xml XML 743999
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 23922934
SIC: 2834 Pharmaceutical Preparations